Literature DB >> 9327076

Assessment of the relationship between isocyanate exposure levels and occupational asthma.

S M Tarlo1, G M Liss, C Dias, D E Banks.   

Abstract

As part of a previous study, we identified Ontario cases of isocyanate-induced occupational asthma (OA) and the companies at which they worked. The Ontario Ministry of Labour maintained a computerized database including isocyanate air sampling determinations conducted by the Ministry. Within this database, we compared levels of isocyanate concentrations measured at 20 case companies [with compensated isocyanate asthma (OA) claims] with 203 noncase companies, based on air samples collected during the same 4-year period during which the OA claims arose. The proportion of case companies that were ever recorded as having a measured ambient isocyanate concentration of > or = 0.005 ppm was greater than that for noncase companies, for TDI users (43% vs 22%), and for MDI users (40% vs 27%). This reached conventional significance when combined across companies and isocyanate types (50% vs 25%; P < 0.05). This provides some evidence that facilities having OA claims have higher isocyanate exposures than do those without claims.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9327076     DOI: 10.1002/(sici)1097-0274(199711)32:5<517::aid-ajim12>3.0.co;2-5

Source DB:  PubMed          Journal:  Am J Ind Med        ISSN: 0271-3586            Impact factor:   2.214


  7 in total

1.  Respiratory symptoms, sensitization, and exposure response relationships in spray painters exposed to isocyanates.

Authors:  Anjoeka Pronk; Liesbeth Preller; Monika Raulf-Heimsoth; Irene C L Jonkers; Jan-Willem Lammers; Inge M Wouters; Gert Doekes; Adam V Wisnewski; Dick Heederik
Journal:  Am J Respir Crit Care Med       Date:  2007-07-26       Impact factor: 21.405

2.  A murine monoclonal antibody with broad specificity for occupationally relevant diisocyanates.

Authors:  Angela R Lemons; Paul D Siegel; Morgen Mhike; Brandon F Law; Justin M Hettick; Toni A Bledsoe; Ajay P Nayak; Donald H Beezhold; Brett J Green
Journal:  J Occup Environ Hyg       Date:  2014       Impact factor: 2.155

Review 3.  Evidence based guidelines for the prevention, identification, and management of occupational asthma.

Authors:  P J Nicholson; P Cullinan; A J Newman Taylor; P S Burge; C Boyle
Journal:  Occup Environ Med       Date:  2005-05       Impact factor: 4.402

4.  Diagnosis and prevention of diseases induced by isocyanate.

Authors:  Kazuko Nakashima; Tatsuya Takeshita; Kanehisa Morimoto
Journal:  Environ Health Prev Med       Date:  2002-05       Impact factor: 3.674

5.  Changes in rates and severity of compensation claims for asthma due to diisocyanates: a possible effect of medical surveillance measures.

Authors:  S M Tarlo; G M Liss; K S Yeung
Journal:  Occup Environ Med       Date:  2002-01       Impact factor: 4.402

Review 6.  Skin exposure to isocyanates: reasons for concern.

Authors:  Dhimiter Bello; Christina A Herrick; Thomas J Smith; Susan R Woskie; Robert P Streicher; Mark R Cullen; Youcheng Liu; Carrie A Redlich
Journal:  Environ Health Perspect       Date:  2006-11-28       Impact factor: 9.031

7.  Opportunities and obstacles in translating evidence to policy in occupational asthma.

Authors:  Susan M Tarlo; Ahmed A Arif; George L Delclos; Paul Henneberger; Jenil Patel
Journal:  Ann Epidemiol       Date:  2017-03-31       Impact factor: 3.797

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.